In Vivo Biodistribution of Engineered Lipid Microbubbles in Rodents.
Journal
ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658
Informations de publication
Date de publication:
20 Aug 2019
20 Aug 2019
Historique:
received:
27
05
2019
accepted:
25
06
2019
entrez:
29
8
2019
pubmed:
29
8
2019
medline:
29
8
2019
Statut:
epublish
Résumé
Maximal resection of intrinsic brain tumors is a major prognostic factor for survival. Real-time intraoperative imaging tools, including ultrasound (US), are crucial for maximal resection of such tumors. Microbubbles (MBs) are clinically used in daily practice as a contrast agent for ultrasound and can be further developed to serve combined therapeutic and diagnostic purposes. To achieve this goal, we have developed novel MBs conjugated to specific ligands to receptors which are overexpressed in brain tumors. These MBs are designed to target a tumor tissue, visualize it, and deliver therapeutic molecules into it. The objective of this study was to assess the biodistribution of the test items: We used MBs labeled with indocyanine green (MB-ICG) for visualization and MBs conjugated to a cyclic molecule containing the tripeptide Arg-Gly-Asp (RGD) labeled with ICG (MB-RGD-ICG) to target brain tumor integrins as the therapeutic tools. Male Sprague Dawley rats received a single dose of each MB preparation. The identification of the MB in various organs was monitored by fluorescence microscopy in anesthetized animals as well as real-time US for brain imaging. Equally sized control groups under identical conditions were used in this study. One control group was used to establish fluorescence background conditions (ICG), and two control groups were used to test autofluorescence from the test items (MBs and MB-RGD). ICG with or without MBs (naked or RGD-modified) was detected in the brain vasculature and also in other organs. The pattern, duration, and intensity of the fluorescence signal could not be differentiated between animals treated with ICG alone and animals treated with microbubbles MBs-ICG or MBs-RGD-ICG. Following MB injection, either naked or combined with RGD, there was a sharp rise in the Doppler signal within seconds of injection in the brain. The signal was mainly located at the choroid plexus, septum pellucidum, and the meninges of the brain. The signal subsided within a few minutes. Injection of saline or ICG alone to respective animals did not result in a similar raised signal. Following a single intravenous administration of MB-ICG and MB-RGD-ICG to rats, the MBs were found to be effectively present in the brain.
Identifiants
pubmed: 31460465
doi: 10.1021/acsomega.9b01544
pmc: PMC6704434
doi:
Types de publication
Journal Article
Langues
eng
Pagination
13371-13381Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
Neurosurg Clin N Am. 2019 Jan;30(1):1-16
pubmed: 30470396
Lancet Oncol. 2006 May;7(5):392-401
pubmed: 16648043
Int J Radiat Biol. 2007 Nov-Dec;83(11-12):743-51
pubmed: 17852562
Ann Surg Oncol. 2017 Mar;24(3):794-800
pubmed: 27766560
Biochem J. 1994 Apr 15;299 ( Pt 2):437-43
pubmed: 8172604
Adv Drug Deliv Rev. 2014 Jun;72:15-27
pubmed: 24316070
J Clin Invest. 1960 Apr;39:592-600
pubmed: 13809697
Br J Cancer. 2013 Jun 25;108(12):2516-24
pubmed: 23652300
Surv Ophthalmol. 2000 Jul-Aug;45(1):15-27
pubmed: 10946079
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Mol Pharm. 2012 Nov 5;9(11):2961-73
pubmed: 22967287
J Drug Target. 2014 Jun;22(5):387-94
pubmed: 24731055
Neurosurg Clin N Am. 2019 Jan;30(1):65-74
pubmed: 30470406
Semin Oncol. 2002 Dec;29(6 Suppl 16):15-8
pubmed: 12516034
J Ultrasound. 2014 Jun 24;17(3):243-51
pubmed: 25177400
J Am Soc Echocardiogr. 2002 May;15(5):396-403
pubmed: 12019422
Br J Radiol. 1997 Jun;70(834):603-11
pubmed: 9227254
Neuro Oncol. 2018 Oct 1;20(suppl_4):iv1-iv86
pubmed: 30445539
Radiology. 2008 Oct;249(1):212-9
pubmed: 18695212
Echocardiography. 1999 Oct;16(7, Pt 2):743-746
pubmed: 11175217
Ultrasound Med Biol. 2010 Jun;36(6):935-48
pubmed: 20447755
Science. 1994 Apr 22;264(5158):569-71
pubmed: 7512751
Lancet Oncol. 2011 Oct;12(11):997-1003
pubmed: 21868284
J Neurosurg. 2011 Jul;115(1):3-8
pubmed: 21417701
Toxicol Pathol. 2012 Jun;40(4 Suppl):14S-86S
pubmed: 22637735
J Biomed Opt. 2009 May-Jun;14(3):034020
pubmed: 19566313
ACS Nano. 2014 Jan 28;8(1):250-9
pubmed: 24303934
ACS Omega. 2019 Mar 19;4(3):5526-5533
pubmed: 31497678
Biochemistry. 2014 Mar 4;53(8):1275-83
pubmed: 24512123